Aplastic anaemia trials in United States
36 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleCancer in Inherited Bone Marrow Failure Syndromes
- Where
- Bethesda, Rockville
- Age
- 1 day to 100 years
- People
- 4,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00027274 - Phase 2Taking peopleAllogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- Where
- Baltimore, Bethesda
- Age
- 4 years to 80 years
- People
- 120
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT01174108 - Phase 1/2Taking peoplePacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- Where
- Bethesda
- Age
- 12 years to 120 years
- People
- 160
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06303193 - No phaseNot yet taking people in United StatesClinical Genetics Branch Eligibility Screening Survey
- Where
- Rockville
- Age
- 1 year to 99 years
- People
- 1,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07005297 - No phaseTaking peopleDefining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
- Where
- Bethesda
- Age
- 8 years to 90 years
- People
- 200
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05687149 - No phaseTaking peopleHPC Offered for PRESERVE Expansion
- Where
- Birmingham, Columbus, Detroit, Duarte, Nashville
- Age
- 12 years to 80 years
- People
- 10
- Run by
- Ossium Health, Inc.
See details and how to joinNCT07145411 - Phase 1/2Taking peopleA Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
- Where
- Atlanta, Cleveland, Columbus, Duarte, Fairfax, Houston, Miami, New York, Palo Alto, Seattle
- Age
- 18 years and over
- People
- 60
- Run by
- Dren Bio
See details and how to joinNCT07712562 - No phaseTaking peopleNatural History of Acquired and Inherited Bone Marrow Failure Syndromes
- Where
- Bethesda
- Age
- 2 years to 99 years
- People
- 1,000
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT05012111 - Phase 2Taking peopleHaplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
- Where
- Bethesda
- Age
- 4 years to 75 years
- People
- 56
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT03520647 - No phaseTaking peopleTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- Where
- Chapel Hill
- Age
- 18 years to 120 years
- People
- 15,000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137643 - Phase 2Taking peopleAlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- Where
- Valhalla
- Age
- 1 day to 30 years
- People
- 20
- Run by
- Mitchell Cairo
See details and how to joinNCT04099966 - No phaseEnrolling by invitationMolecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study
- Where
- Bethesda
- Age
- 2 years to 120 years
- People
- 1,400
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT07102849 - Phase 2Taking peopleHaploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
- Where
- Atlanta
- Age
- 1 year to 75 years
- People
- 20
- Run by
- Northside Hospital, Inc.
See details and how to joinNCT02828592 - Early phase 1Taking peopleDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Where
- Baltimore
- Age
- 18 years and over
- People
- 8
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06398457 - Phase 1/2Taking peopleUnrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- Where
- Bethesda
- Age
- 4 years to 75 years
- People
- 37
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT03173937 - Phase 2Taking peopleHaploidentical HCT for Severe Aplastic Anemia
- Where
- Memphis
- Age
- Up to 21 years
- People
- 21
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT04558736 - No phaseTaking peopleThe HOPE Biobank Resource (BMT CTN 2402 HOPE)
- Where
- Atlanta, Chicago, Duarte, Durham, Gainesville, Houston, Milwaukee, Nashville, New York, Portland, Richmond, Seattle, St Louis
- People
- 375
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07227155 - No phaseTaking peopleA Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Where
- Akron, Amarillo, Ann Arbor, Atlanta, Augusta, Aurora, Baltimore, Beech Grove, Bethesda, Birmingham, Boston, Brandywine, Buffalo, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Denver, Detroit, Duarte, Durham, Fort Sam Houston, Fort Worth, Gainesville, Gilbert, Glendale, Grand Rapids, Hackensack, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, La Jolla, Lake Sucess, Little Rock, Loma Linda, Los Angeles, Louisville, Lubbock, Madison, Maywood, Memphis, Miami, Milwaukee, Morgantown, Nashville, New Brunswick, New Haven, New Hyde, New Orleans, New York, Oakland, Oklahoma City, Omaha, Orange, Orlando, Park Ridge, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Rochester, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Stanford, St Louis, Stony Brook, St. Petersburg, Tampa, The Bronx, Tucson, Washington D.C., Westwood, Winston-Salem, Worcester, Zion
- People
- 99,999
- Run by
- Center for International Blood and Marrow Transplant Research
See details and how to joinNCT01351545 - Phase 2Taking peopleTCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- Where
- St. Petersburg
- Age
- 0 years to 21 years
- People
- 17
- Run by
- Johns Hopkins All Children's Hospital
See details and how to joinNCT04356469 - Phase 2Taking peopleMethylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- Where
- Houston
- Age
- 18 years and over
- People
- 140
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT01624805 - Phase 1/2Not yet taking people in United StatesPrenatal Transplantation for Fetuses With Fanconi Anemia
- Where
- San Francisco, Stanford
- People
- 12
- Run by
- Agnieszka Czechowicz
See details and how to joinNCT07408583 - No phaseTaking peopleInvestigation of the Genetics of Hematologic Diseases
- Where
- Memphis
- People
- 1,716
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT02720679 - No phaseTaking peopleLet's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
- Where
- St Louis
- Age
- 8 years and over
- People
- 60
- Run by
- Washington University School of Medicine
See details and how to joinNCT06689800 - Phase 2Taking peopleMT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
- Where
- Minneapolis
- Age
- 0 years to 75 years
- People
- 60
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT06412497 - Phase 1/2Taking peoplePhase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
- Where
- Philadelphia
- Age
- 1 month to 25 years
- People
- 100
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT06839456